The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The preliminary efficacy and safety results of neoadjuvant phase II study of anlotinib plus tislelizumab combined with chemotherapy in triple-negative breast cancer.
 
Jing Luo
No Relationships to Disclose
 
Jie Chen
No Relationships to Disclose
 
Xuchu Jin
No Relationships to Disclose
 
Liangquan Liu
No Relationships to Disclose
 
Lin Zhong
No Relationships to Disclose
 
Yi Li
No Relationships to Disclose
 
Chihua Wu
No Relationships to Disclose
 
Jing Fu
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose